Tissue engineering and regenerative medicine are interdisciplinary fields focused on developing biological substitutes to restore, maintain, or enhance tissue function, or to replace diseased and damaged tissues. These fields are applicable to both hard tissues, such as bone and cartilage, and soft tissues, like skin and cardiovascular valves. The process of tissue engineering involves three key components: cells, scaffolds, and growth-stimulating signals, which work together to create functional tissue substitutes. While tissue engineering primarily focuses on culturing tissues in vitro, regenerative medicine expands on this by combining tissue engineering techniques with additional strategies such as cell-based therapies, gene therapy, and immunomodulation, all aimed at promoting tissue regeneration within the body (in vivo). Biomimetic tissue constructs are also developed as in vitro models for drug screening and disease modeling, helping to better understand biological processes and test new treatments. The core principle of tissue engineering involves growing new tissue in the laboratory by combining scaffolds, native tissue cells, and bioactive molecules to mimic the body’s natural biological processes and regenerate healthy tissue.
Tissue scaffolds serve a crucial role in tissue engineering, mimicking the functions of the extracellular matrix (ECM) found in native tissues. These scaffolds provide a supportive environment for cells to grow, migrate, and respond to various biological signals. By offering mechanical strength and structural integrity, tissue scaffolds help to maintain the architecture of the newly formed tissue. Additionally, scaffolds offer bioactive cues that regulate cellular activity, encouraging processes such as proliferation, differentiation, and tissue remodeling. As a result, they play a vital role in promoting the regeneration of functional tissues, particularly in areas such as wound healing, organ regeneration, and implantable devices.
To create tissue scaffolds that accurately mimic the functions of native ECM, three major approaches have been developed, each offering distinct advantages for specific tissue engineering applications:
Each of these methods offers unique capabilities and is suited to different applications in regenerative medicine and tissue engineering, advancing the development of functional tissues and organs for medical use.